BAL's has had nothing but issues. I do believe that Andrew Cohen, while he thinks that China latest policy change is not significant to report, it is a reportable announcement. Revenue will benefit from this.
BAL's current position of China sales though CBEC is reported as being 26%. Does he think it won't grow?
He should at least shine some light on SAMR and latest changes in CBEC and how they intertwine.
The fact is BAL's has incredibly attractive Price to Free Cashflow ratio (PFCF). It is sitting at around 14.19 [Variables ; Share Price 7.6, Issued Shares 113.37m, Free cashflow ($m) 60.7, Free cashflow EPS 0.535]
This acts as a fundamental cushion and entry point for most value buyers. This maybe one of the reason when you see BAL drift below 7.40, buyers are coming out of the woods.
BAL Price at posting:
$7.60 Sentiment: Buy Disclosure: Held